Abstract
Background:
Obesity is an increasing health problem and surgery seems to be the only treatment effective in achieving weight loss without relapse. Among bariatric techniques, many differences exist in terms of weight loss and resolution of comorbidities. Up to now, there are no prospective studies comparing long-term effects of malabsorptive vs restrictive techniques.
Objective:
In this study, cardiometabolic risk factors and body composition changes after malabsorptive biliointestinal bypass (BIBP) and restrictive laparoscopic adjustable gastric banding (LAGB) were compared during a 4-year follow-up.
Design:
Prospective, case–control and cohort study.
Patients:
In all, 80 obese subjects, matched for weight and age. Altogether, 40 patients underwent BIBP and 40 underwent LAGB.
Measurements:
Weight, body composition, fasting and post-loading plasma glucose and insulin, homeostatic model assessment index (HOMA-I), lipid profile, blood pressure (BP), erythrocyte sedimentation rate and fibrinogen were monitored at baseline, 12 and 48 months.
Results:
At 12 months after surgery, a significant reduction in body mass index, total fat mass (FM), trunk FM (trFM), trFM/legs FM (lFM) ratio (trFM/lFM), triglycerides, BP and inflammation markers was observed in both groups. BIBP patients showed a significant reduction in total cholesterol (Tot-C), low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C), whereas the LAGB group showed a significant increase of HDL-C. A further improvement of all the parameters evaluated was seen in the BIBP group at 48 months after surgery.
Conclusions:
Both bariatric procedures exerted positive effects on cardiometabolic risk factors and on weight loss in the population studied, but on the long-term period, HOMA-I, Tot-C/HDL-C ratio and body composition improvements were more evident after BIBP. We conclude that malabsorptive BIBP seems to be more effective than LAGB in treating visceral obesity and its metabolic complications
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bult MJ, van Dalen T, Muller AF . Surgical treatment of obesity. Eur J Endocrinol 2008; 158: 135–145.
Haslam DW, James WP . Obesity. Lancet 2005; 366: 1197–1209.
Stevens VJ, Obarzanek E, Cook NR, Lee IM, Appel LJ, Smith West D et al. Long term weight loss and changes in blood pressure: results of the trials of hypertension prevention, phase II. Ann Intern Med 2001; 134: 1–11.
Dixon JB, Pories WJ, O’Brien PE, Schauer PR, Zimmet P . Surgery as an effective early intervention for diabesity: why the reluctance? Diabetes Care 2005; 28: 472–474.
Poobalan AS, Aucott LS, Smith WC, Avenell A, Jung R, Broom J . Long-term weight loss effects on all cause mortality in overweight/obese populations. Obesity Rev 2007; 8: 503–513.
De Maria EJ . Bariatric surgery for morbid obesity. N Engl J Med 2007; 356: 2176–2183.
Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292: 1724–1737.
Rubino F, Gagner M . Potential of surgery for curing type 2 diabetes mellitus. Ann Surg 2002; 236: 554–559.
Levy P, Fried M, Santini F, Finer N . The comparative effects of bariatric surgery on weight and type 2 diabetes. Obes Surg 2007; 17: 1248–1256.
Vogel JA, Franklin BA, Zalesin KC, Trivax JE, Krause KR, Chengelis DL et al. Reduction in predicted coronary heart disease risk after substantial weight reduction after bariatric surgery. J Am Cardiol 2007; 99: 222–226.
Corradini SG, Eramo A, Lubrano C, Spera G, Cornoldi A, Grossi A et al. Comparison of changes in lipid profile after bilio-intestinal bypass and gastric banding in patients with morbid obesity. Obes Surg 2005; 15: 367–377.
Flum DR, Salem L, Elrod JA, Dellinger EP, Cheadle A, Chan L . Early mortality among Medicare beneficiaries undergoing bariatric surgical procedures. JAMA 2005; 294: 1903–1908.
NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med 1991; 115: 956–961.
Marcus MD, Kalarchian MA . Courcoulas AP Psychiatric evaluation follow-up of bariatric surgery patients. Am J Psychiatry 2009; 166: 285–291.
Grundy SM, Brewer HM, Cleeman JI, Smith SC, Lenfant C . Definition of Metabolic Syndrome Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433–438.
Mechanick JI, Kushner RF, Sugerman HJ, Gonzalez-Campoy JM, Collazo-Clavell ML, Spitz AF et al. American Association of Clinical Endocrinologists, The Obesity Society, and American Society For Metabolic & Bariatric surgery medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Obesity 2009; 17 (s1): s1–s70.
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2000; 23 (Suppl. 1): S4–S19.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419.
Andreoli A, Scalzo G, Masala S, Tarantino U, Guglielmi G . Body composition assessment by dual-energy X-ray absorptiometry (DXA). Radiol Med 2009; 114: 286–300.
Boorsma W, Snijder MB, Nijpels G, Guidone C, Favuzzi AMR, Mingrone G et al. Body composition, insulin sensitivity, and cardiovascular disease profile in healthy Europeans. Obesity 2008; 16: 2696–2701.
Rahman M, Temple J, Breitkopf C, Berenson A . Racial differences in body fat distribution among reproductive-aged women. Metab Clin Exp 2009; 58: 1329–1337.
Tsutomu D, Yukie Y, Yukie K, Akiko K, Tomoki K, Ichiro I . Difference in segmental lean and fat mass components between pre- and postmenopausal women. Menopause 2007; 14: 875–878.
Haasen G, Fagertum H, Tonstad S, Halse J . Leg fat mass as measured by dual X-ray absorptiometry (DXA) impacts insulin resistance differently in obese women versus men. Scand J Clin Lab Invest 2009; 69: 181–189.
Haasen G, Fagertun H, Halse J . Insulin resistance and dyslipidaemia in obese premenopausal and postmenopausal women matched for leg/trunk fat mass ratio. Scand J Clin Lab Invest 2009; 69: 505–511.
Micheletto G, Mozzi E, Lattuada E, Lanni M, Perrini M, Caccialanza R et al. The biliointestinal bypass. Ann Ital Chir 2007; 78: 27–30.
Bressani Doldi S, Lattuada E, Zappa MA, Pieri G, Restelli A, Micheletto G . Biliointestinal bypass: another surgical option. Obes Surg 1998; 8: 566–569.
Boman L, Domellöf L . Biliary-intestinal bypass in the treatment of obesity: long-term follow-up. Eur J Surg 1998; 164: 943–949.
Micheletto G, Badiali M, Danelli PG, Sacco R, Sala B, Bressani Doldi S . The biliointestinal bypass: a thirty-years experience. Ann Ital Chir 2008; 79: 419–426.
Badiali M, D’Agostini A, Filippis AM, Corradini SG, Grossi A, Eramo A et al. Patency of anastomoses after bilio-intestinal bypass: radioisotope demonstration. Obes Surg 2001; 11: 615–618.
Favretti F, Cadiere GB, Segato G, Segato G, Bruyns G, De Marchi F et al. Laparoscopic adjustable silicone gastric banding: technique and results. Obes Surg 1995; 5: 364–371.
Tice JA, Karliner L, Walsh J, Petersen AJ, Feldman MD . Gastric banding or bypass? A systematic review comparing the two most popular bariatric procedures. Am J Med 2008; 121: 885–893.
Santry HP, Gillen DL, Lauderdale DS . Trends in bariatric surgical procedures. JAMA 2005; 294: 1909–1917.
Sjöström L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B et al. Lifestyle, diabetes and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351: 2683–2693.
Vetter ML, Cardillo S, Rickels MR, Iqbal N . Narrative review: effect of bariatric surgery on type 2 diabetes mellitus. Ann Intern Med 2009; 150: 94–103.
Sjöström L, Narbro K, Sjöström CD, Karason K, Larsson B, Wedel H et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007; 357: 741–752.
Renehan AG, Roberts DL, Dive C . Obesity and cancer: pathophysiological and biological mechanisms. Arch Physiol Biochem 2008; 114: 71–83.
Gagné DJ, Papasavas PK, Maalouf M, Urbandt JE, Caushaj PF . Obesity surgery and malignancy: our experience after 1500 cases. Surg Obes Relat Dis 2008; 5: 160–164.
Frigè F, Laneri M, Veronelli A, Folli F, Paganelli M, Vedani P et al. Bariatric surgery in obesity: changes of glucose and lipid metabolism correlate with changes of fat mass. Nutr Metab Cardiovasc Dis 2009; 19: 198–204.
Després JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 2008; 28: 1039–1049.
Lee K, Lee S, Kim YJ, Kim YJ . Waist circumference, dual-energy X-ray absortiometrically measured abdominal adiposity, and computed tomographically derived intra-abdominal fat area on detecting metabolic risk factors in obese women. Nutrition 2008; 24: 625–631.
Nelson TL, Bessesen DH, Marshall JA . Relationship of abdominal obesity measured by DXA and waist circumference with insulin sensitivity in hispanic and non-hispanic white individuals: the San Luis Valley diabetes study. Diabetes Metab Res Rev 2008; 24: 33–40.
Stefan N, Kantartzis K, Machann J, Schick F, Thamer C, Rittig K et al. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 2008; 168: 1609–1616.
Lubrano C, Cornoldi A, Pili M, Falcone S, Brandetti F, Fabbrini E et al. Reduction of risk factors for cardiovascular diseases in morbid-obese patients following biliary-intestinal bypass: 3 years follow-up. Int J Obes Relat Metab Disord 2004; 28: 1600–1606.
Dixon JB, O’Brien PE . Lipid profile in the severely obese: changes with weight loss after lap-band surgery. Obes Res 2002; 10: 903–910.
Fruchart JC, Sacks F, Hermans MP, Assmann G, Brown WV, Ceska R et al. The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia. Am J Cardiol 2008; 102: 1K–34K.
Ferrannini E, Mingrone G . Impact of different bariatric surgical procedures on insulin action and beta-cell function in type 2 diabetes. Diabetes Care 2009; 32: 514–520.
Spanakis E, Gragnoli C . Bariatric surgery, safety and type 2 diabetes. Obes Surg 2009; 19: 363–368.
Purnell JQ, Flum DR . Bariatric surgery and diabetes: who should be offered the option of remission? JAMA 2009; 301: 1593–1595.
Guidone C, Manco M, Valera-Mora E, Iaconelli A, Gniuli D, Mari A et al. Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes 2006; 55: 2025–2031.
Parikh M, Ayoung-Chee P, Romanos E, Lewis N, Pachter HL, Fielding G et al. Comparison of rates of resolution of diabetes mellitus after gastric banding, gastric bypass, and biliopancreatic diversion. J Am Coll Surg 2007; 205: 631–635.
Compher C, Badellino KO . Obesity and inflammation: lessons from bariatric surgery. J Parenter Enteral Nutr 2008; 32: 645–647.
Anuurad E, Tracy RP, Pearson TA, Kim K, Berglund L . Synergistic role of inflammation and insulin resistance as coronary artery disease risk factors in African Americans and Caucasians. Atherosclerosis 2009; 205: 290–295.
Acknowledgements
This work was supported in part by the Italian Ministry of Health, Progetto di Ricerca Finalizzato 2005, University of Rome ‘Sapienza’, Faculty of Medicine.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Lubrano, C., Mariani, S., Badiali, M. et al. Metabolic or bariatric surgery? Long-term effects of malabsorptive vs restrictive bariatric techniques on body composition and cardiometabolic risk factors. Int J Obes 34, 1404–1414 (2010). https://doi.org/10.1038/ijo.2010.54
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ijo.2010.54
Keywords
This article is cited by
-
Evaluation of Lipoprotein Profile and Residual Risk Three Years After Bariatric Surgery
Obesity Surgery (2021)
-
A 9Â years comparison of weight loss, disappearance of obesity, and resolution of diabetes mellitus with biliointestinal bypass and with adjustable gastric banding: experience of a collaborative network
Acta Diabetologica (2019)
-
The Effect of the Bariatric Surgery Type on the Levothyroxine Dose of Morbidly Obese Hypothyroid Patients
Obesity Surgery (2018)
-
Lipid changes 8 years post gastric bypass in adolescents with severe obesity (FABS-5+ study)
International Journal of Obesity (2017)
-
Changes in adiposity and other cardiometabolic risk factors following Roux-en-Y gastric bypass: A 12-month prospective cohort study in Chinese patients
Indian Journal of Gastroenterology (2017)